About: Genetically modified fish is a research topic. Over the lifetime, 17 publications have been published within this topic receiving 159 citations. The topic is also known as: GM fish.
TL;DR: Gene technology opens new opportunities to comprehend the nature of the genetic variation underlying production traits, enabling improvement in economically important traits, in particular traits difficult to breed for, such as food conversion efficiency and disease resistance.
Abstract: Selective breeding has been very successful in increasing production in Atlantic salmon. Gene technology opens new opportunities to comprehend the nature of the genetic variation underlying production traits. Two major areas in which gene technology may play an important role are (1) production of genetically modified fish and (2) development and utilization of genetic markers. Several studies of transgenic salmonids have shown substantially increased growth rates. However, many different issues are related to whether genetically modified fish should be used or not. Genetic markers can be used for aquaculture purposes and for monitoring wild populations. Construction of genetic maps based on markers enables the identification of quantitative trait loci (QTL) and/or markers linked to them. This will facilitate marker-assisted selection, enabling improvement in economically important traits, in particular traits difficult to breed for, such as food conversion efficiency and disease resistance. Several experiments aimed at mapping QTL in salmonids using genetic markers are ongoing. DNA marker technologies can also be used for identification and monitoring of lines, families and individuals, and for genetic improvement through selection for favourable genes and gene combinations.
TL;DR: The United States Food and Drug Administration (FDA) announced on November======16, 2015 that the genetically modified AquAdvantage Salmon is as safe to eat as non-GMO salmons, and can now be legally marketed as food.
Abstract: The US Food and Drug Administration (FDA) announced on November
16, 2015 that the genetically modified AquAdvantage Salmon is as safe
to eat as non-GMO salmons. This means that the genetically modified
fish has finally been approved by the sole authority in this field-FDA-in
the United States, and can now be legally marketed as food. It is
worth noting that the world’s first institute to obtain a genetically
modified fish was the Institute of Hydrobiology, the Chinese Academy
of Sciences, whose research remains, even now, at the forefront of
the researches in the world, but has not yet been commercialized.
This is a fact that deserves out reflections. The current Chinese
legislation on transgenic plants, animals and foods can no longer
account for the emergence of new biotechnologies, especially the gene-edit
technology. In July 2015, the US President’s Office of Science
and Technology Policy sent a memorandum entitled “Modernizing
the Regulatory System for Biotechnology Products” to the Department
of Agriculture, FDA, and the Environmental Protection Agency, requiring
them to produce a draft regulation in one year for further discussion.
How to amend Chinese regulations and policies concerning China’s
biotechnology industry needs the combined efforts of scientists, legal
experts, and government officials, who should conduct comprehensive
discussions of and make decisions on the industrialization of biotechnology.